Cormedix Therapeutics
Clinical trials sponsored by Cormedix Therapeutics, explained in plain language.
-
New catheter lock aims to stop deadly infections in home nutrition patients
Disease control Recruiting nowThis phase 3 trial tests whether a catheter lock solution called DefenCath can prevent central line-associated bloodstream infections (CLABSIs) in adults who receive total parenteral nutrition (TPN) at home through a central line. About 200 participants will be randomly assigned …
Phase: PHASE3 • Sponsor: CorMedix Therapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New hope for kids on dialysis: drug may stop deadly infections
Disease control Recruiting nowThis study tests a drug called DefenCath, a liquid placed inside dialysis catheters, to see if it prevents bloodstream infections better than standard care. It involves 36 children from birth to under 18 years old with kidney failure who need hemodialysis. The goal is to keep cat…
Phase: PHASE4 • Sponsor: CorMedix Therapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC